MarketCap
Facebook
X
Telegram
QIAGEN N.V. Shares | QGEN
Annual Shares QIAGEN N.V.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 217 M | 223 M | 228 M | 228 M | 228 M | 228 M | 227 M | 227 M | 228 M | 226 M | 224 M | 223 M | 225 M | 226 M | 226 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 228 M | 217 M | 226 M |
Quarterly Shares QIAGEN N.V.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 236 M | - | - | - | 234 M | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 236 M | 234 M | 235 M |
Shares of other stocks in the Diagnostics research industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B |  USA |
 |
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | USA |
 |
Syneos Health
SYNH
|
103 M | - | - | $ 4.46 B | USA |
 |
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K |  Israel |
 |
Renalytix AI plc
RNLX
|
108 M | - | 5.66 % | $ 22.7 M |  Britain |
 |
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Psychemedics Corporation
PMD
|
5.87 M | - | -1.84 % | $ 15.3 M | USA |
 |
Quotient Limited
QTNT
|
102 M | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
T2 Biosystems
TTOO
|
2.61 M | - | -39.35 % | $ 313 K | USA |
 |
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | USA |
 |
Bioventus
BVS
|
66.6 M | $ 13.0 | 1.39 % | $ 866 M | USA |
 |
DarioHealth Corp.
DRIO
|
3.98 M | $ 6.75 | 2.31 % | $ 26.9 M | Israel |
 |
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
23.3 M | - | -61.36 % | $ 2.46 M | USA |
 |
Anixa Biosciences
ANIX
|
32.5 K | $ 2.69 | 1.45 % | $ 87.3 K | USA |
 |
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | USA |
|
Biodesix
BDSX
|
7.55 M | $ 27.7 | 1.09 % | $ 209 M | USA |
 |
BioNano Genomics
BNGO
|
5.44 M | $ 1.56 | 17.29 % | $ 8.49 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
82.1 M | $ 11.68 | 0.69 % | $ 123 M |  China |
 |
CareDx, Inc
CDNA
|
53.3 M | $ 52.64 | 0.52 % | $ 2.81 B | USA |
 |
Celcuity
CELC
|
46.8 M | $ 82.7 | 0.1 % | $ 3.87 B | USA |
 |
Co-Diagnostics
CODX
|
1.33 M | $ 1.14 | 2.7 % | $ 1.52 M | USA |
 |
Charles River Laboratories International
CRL
|
49.6 M | $ 272.88 | 0.59 % | $ 13.5 B | USA |
 |
Castle Biosciences
CSTL
|
29 M | $ 35.5 | 6.16 % | $ 1.03 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
111 M | $ 247.08 | 3.9 % | $ 27.4 B | USA |
 |
Meridian Bioscience
VIVO
|
43.6 M | - | - | $ 1.49 B | USA |
 |
Biomerica
BMRA
|
2.91 M | $ 2.3 | 0.42 % | $ 6.7 M | USA |
 |
Fulgent Genetics
FLGT
|
30.8 M | $ 21.28 | 3.05 % | $ 655 M | USA |
 |
Guardant Health
GH
|
125 M | $ 175.65 | 4.65 % | $ 22 B | USA |
 |
ICON Public Limited Company
ICLR
|
78.4 M | $ 172.45 | 2.08 % | $ 13.5 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
80.4 M | $ 510.73 | 0.23 % | $ 41.1 B | USA |
 |
Danaher Corporation
DHR
|
713 M | $ 209.36 | 3.01 % | $ 149 B | USA |
 |
Illumina
ILMN
|
155 M | $ 222.29 | 6.76 % | $ 34.5 B | USA |
 |
IQVIA Holdings
IQV
|
172 M | $ 269.67 | 1.51 % | $ 46.4 B | USA |
 |
Brainsway Ltd.
BWAY
|
34 M | $ 13.46 | 0.14 % | $ 457 M | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
83.2 M | $ 323.97 | 2.75 % | $ 27 B | USA |
 |
Lantheus Holdings
LNTH
|
67.5 M | $ 100.73 | 0.41 % | $ 6.8 B | USA |
 |
DexCom
DXCM
|
390 M | $ 86.45 | 2.09 % | $ 33.7 B | USA |
 |
Medpace Holdings
MEDP
|
28.8 M | $ 620.48 | 4.21 % | $ 17.9 B | USA |
 |
Mettler-Toledo International
MTD
|
20.6 M | $ 1 330.4 | 3.47 % | $ 27.4 B | Schweiz |
 |
Myriad Genetics
MYGN
|
92.6 M | $ 3.88 | 2.37 % | $ 359 M | USA |
 |
ENDRA Life Sciences
NDRA
|
787 K | $ 5.66 | 1.13 % | $ 4.45 M | USA |
 |
NeoGenomics
NEO
|
128 M | $ 18.89 | 2.61 % | $ 2.42 B | USA |
 |
Neogen Corporation
NEOG
|
218 M | $ 12.25 | 2.51 % | $ 2.66 B | USA |
 |
National Research Corporation
NRC
|
22.4 M | $ 21.96 | 5.63 % | $ 492 M | USA |
 |
Natera
NTRA
|
137 M | $ 350.78 | 2.63 % | $ 48 B | USA |
 |
OPKO Health
OPK
|
751 M | $ 1.57 | 0.64 % | $ 1.18 B | USA |
 |
Pacific Biosciences of California
PACB
|
300 M | $ 1.34 | 0.37 % | $ 402 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
948 M | $ 24.9 | 1.99 % | $ 23.6 B |  Niderland |
 |
Personalis
PSNL
|
89.2 M | $ 16.1 | 0.31 % | $ 1.44 B | USA |